Health/Fastest growing

CoMind

Builds non-invasive bedside devices that monitor brain blood flow and pressure in critically ill patients.

Why it's here

Raised $102.5M in October 2025 led by Plural, with Angelini Ventures, LocalGlobe and Octopus Ventures participating.

Focus: Neuromonitoring
Founded: 2018
Latest round: $102.5M, Oct 2025
Staff (Companies House accounts): 54, average over the period to 31 Dec 2025source: find-and-update.company-information.service.gov.uk
London office: 2nd Floor, 210 Pentonville Road, Islington N1 9JYsource: find-and-update.company-information.service.gov.uk
London presence: HQsource: builtinlondon.uk
Investors: Plural (lead), Angelini Ventures, BACKED VC, Crane Venture Partners, Entrepreneur First, LocalGlobe, Octopus Venturessource: comind.io
Area: King's Cross
Nearest station: King's Cross & St Pancras International, 247 m
Companies House: COMIND TECHNOLOGIES LIMITED (11729526, active)Incorporated 17 Dec 2018 · SIC 62090
Hiring: 9 open roles in London ↗Public job board, checked 9 Oct 2026
Work model: On-site (from 9 London job posts)Current job posts only, checked 9 Oct 2026. Howsource: jobs.ashbyhq.com
Visas: Licensed visa sponsor, listed as CoMind Technologies Limitedsource: gov.uk

Same building

One more company on the map lists this office address.